COSCIENS Biopharma Inc. Financial Liabilities At Fair Value Through Profit Or Loss
COSCIENS Biopharma Inc. (CSCIF) had Financial Liabilities At Fair Value Through Profit Or Loss of $3.63 million as of 2018-12-31, per its 20-F filed 2019-04-01.
Discontinued › Notes
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss · last filed 2019-04-01
- 2018-12-31: Financial Liabilities At Fair Value Through Profit Or Loss $3.63M.
- 2017-12-31: Financial Liabilities At Fair Value Through Profit Or Loss $3.90M.
- 2016-12-31: Financial Liabilities At Fair Value Through Profit Or Loss $6.85M.
- 2015-12-31: Financial Liabilities At Fair Value Through Profit Or Loss $10.89M.
| Period end | Financial Liabilities At Fair Value Through Profit Or Loss |
|---|---|
| 2018-12-31 | $3.63M 20-F · filed 2019-04-01 |
| 2017-12-31 | $3.90M 20-F · filed 2019-04-01 |
| 2016-12-31 | $6.85M 20-F · filed 2019-04-01 |
| 2015-12-31 | $10.89M 20-F · filed 2019-04-01 |
| 2014-12-31 | $8.22M 20-F · filed 2018-03-28 |